CureVac Wins Key mRNA Patent Battle Against BioNTech in Europe | CVAC Stock News

CureVac (NASDAQ:CVAC) has achieved a significant legal victory as the European Patent Office (EPO) largely dismissed BioNTech SE’s opposition to …